Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTD402 in Relapsed/Refractory T-ALL and T-LBL
NCT07070219Phase 2Recruiting
- Sponsor
- Imviva
- Start
- Oct 2025
- Primary completion
- Sep 2028
- Countries
- 2
01
Overview
A Phase 2 trial of CD7-CAR T cells in acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), sponsored by Imviva. Started Oct 2025; status: recruiting.
02
Drugs
CD7-CAR T cells
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT07070219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07070219.